Uncertainty around potential policy changes from President Trump has done little to deter the stock market rally in 2025 with ...

US equity indexes fell intraday Thursday as markets evaluated the latest macro data and corporate news that included a weak earnings outlook from Walmart (WMT). The Nasdaq Composite and the S&P 500 ...

Uncertainty over cuts to military spending have hammered key contractors in recent weeks. The worst-feared scenario doesn’t ...

Tesla stock was rising early Thursday as investors continued to weigh the risks and rewards associated with CEO Elon Musk.The ...

Wedbush analyst Robert Driscoll initiated coverage of Avalo Therapeutics (AVTX) with an Outperform rating and $18 price target Discover the ...

In a report released today, Yun Zhong from Wedbush maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report), with a price ...

Palantir Technologies received a new Buy rating from Loop Capital and continued bullish support from Wedbush on Thursday, despite recent market concerns over potential U.S. defense budget cuts.

Investing.com -- Apple's (NASDAQ:AAPL) partnership with Alibaba (NYSE:BABA) as part of its China AI strategy marks “a big step forward” for the technology giant, Wedbush analyst Daniel Ives ...

Investing.com -- Apple's (NASDAQ:AAPL) partnership with Alibaba (NYSE:BABA) as part of its China AI strategy marks “a big step forward” for the technology giant, Wedbush analyst Daniel Ives said in a ...

Wedbush analyst M. Pachter now expects that the company will post earnings per share of $2.30 for the year, down from their prior forecast of $2.31. Wedbush currently has a “Outperform” rating ...

Welltower (NYSE:WELL) was upgraded at Wedbush after the senior housing REIT "impressed with the growth outlook for 2025". The healthcare REIT turned in Q4 earnings and revenue that topped Wall ...

Nuclear energy stocks are glowing green and emerging as top contenders in the 2025 “Trump Trades” arena. Experts note that ...